Last reviewed · How we verify
Neuroblastoma
Approved treatments
- Oncovin · University of Colorado, Denver
- Vincristin · Arbeitsgemeinschaft medikamentoese Tumortherapie
- adriacin · Chipscreen Biosciences, Ltd.
- Hydroxydaunorubicin · University of Colorado, Denver
- Cyclophosphamid · Zhejiang University
- DANYELZA · Y-MABS THERAPEUTICS INC
Naxitamab-gqgk binds to GD2 on neuroblastoma cells, inducing CDC and ADCC. - Busilvex · medac GmbH
- Hu3F8 · Y-Mabs Therapeutics Inc
Hu3F8 works by binding to a specific glycolipid on cancer cells, marking them for destruction by the immune system. - Cytoxan (Lyophilized) · Baxter
Cyclophosphamide cross-links tumor cell DNA and interferes with malignant cell growth through active alkylating metabolites. - Oncovin · Pfizer Inc.
- Oncovin · Pfizer Inc.
- Liposomal Doxorubicin · Pfizer
- Busulfex · Waylis
Busulfex works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and ultimately leading to cell death. - Doxorubicin Hydrochloride · Pfizer
Doxorubicin works by intercalating DNA strands and inhibiting topoisomerase II, an enzyme essential for DNA replication and cell division. - Cytoxan (Lyophilized) · Baxter
Cytoxan works by interfering with the DNA replication process in rapidly dividing cancer cells. - Ch14.18 · United Therap
Dinutuximab binds to GD2 on neuroblastoma cells and induces cell lysis via ADCC and CDC. - Hydroxydaunomycin · Weill Medical College of Cornell University
- Adriamycin · Johann Wolfgang Goethe University Hospital
- busulfex · Dana-Farber Cancer Institute
- Busulphan · University of Birmingham
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Neuroblastoma patent landscape — cliff calendar, originator estates, attackable patents
- Neuroblastoma treatment landscape brief
- Neuroblastoma treatment updates RSS
Frequently asked questions about Neuroblastoma
What drugs treat Neuroblastoma?
Tracked treatments include Oncovin, Vincristin, adriacin, Hydroxydaunorubicin, Cyclophosphamid, DANYELZA, Busilvex, Hu3F8.
What is the treatment for Neuroblastoma?
Standard treatment for Neuroblastoma includes Oncovin, Vincristin, adriacin, Hydroxydaunorubicin, Cyclophosphamid. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Neuroblastoma patent cliff · Neuroblastoma CI report
- Treatment: Oncovin · University of Colorado, Denver
- Treatment: Vincristin · Arbeitsgemeinschaft medikamentoese Tumortherapie
- Treatment: adriacin · Chipscreen Biosciences, Ltd.
- Treatment: Hydroxydaunorubicin · University of Colorado, Denver
- Treatment: Cyclophosphamid · Zhejiang University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing